BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23033440)

  • 1. Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients.
    Dimitrakopoulou-Strauss A; Pan L; Strauss LG
    Cancer Imaging; 2012 Sep; 12(1):283-9. PubMed ID: 23033440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric imaging: a promising approach for the evaluation of dynamic PET-18F-FDG studies - the DKFZ experience.
    Dimitrakopoulou-Strauss A; Pan L; Strauss LG
    Hell J Nucl Med; 2010; 13(1):18-22. PubMed ID: 20411165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
    Dimitrakopoulou-Strauss A; Strauss L
    Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic PET with FDG in patients with unresectable aggressive fibromatosis: regression-based parametric images and correlation to the FDG kinetics based on a 2-tissue compartment model.
    Dimitrakopoulou-Strauss A; Hohenberger P; Pan L; Kasper B; Roumia S; Strauss LG
    Clin Nucl Med; 2012 Oct; 37(10):943-8. PubMed ID: 22899201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.
    Guo J; Guo N; Lang L; Kiesewetter DO; Xie Q; Li Q; Eden HS; Niu G; Chen X
    J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
    Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?
    Strauss LG; Klippel S; Pan L; Schönleben K; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):868-77. PubMed ID: 17219134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of new bone formation in normal and osteoporotic rats with a 3-mm femur defect: functional assessment with dynamic PET-CT (dPET-CT) using 2-deoxy-2-[(18)F]fluoro-D-glucose ( (18)F-FDG) and (18)F-fluoride.
    Cheng C; Alt V; Dimitrakopoulou-Strauss A; Pan L; Thormann U; Schnettler R; Weber K; Strauss LG
    Mol Imaging Biol; 2013 Jun; 15(3):336-44. PubMed ID: 22965489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate total-body K
    Chen Z; Cheng Z; Duan Y; Zhang Q; Zhang N; Gu F; Wang Y; Zhou Y; Wang H; Liang D; Zheng H; Hu Z
    Med Phys; 2023 Apr; 50(4):2121-2134. PubMed ID: 35950784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First results on kinetic modelling and parametric imaging of dynamic
    Sari H; Mingels C; Alberts I; Hu J; Buesser D; Shah V; Schepers R; Caluori P; Panin V; Conti M; Afshar-Oromieh A; Shi K; Eriksson L; Rominger A; Cumming P
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1997-2009. PubMed ID: 34981164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response evaluation with
    Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives.
    Dimitrakopoulou-Strauss A; Pan L; Sachpekidis C
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):21-39. PubMed ID: 32430580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal analysis of tumor uptake patterns in dynamic (18)FDG-PET and dynamic contrast enhanced CT.
    Malinen E; Rødal J; Knudtsen IS; Søvik Å; Skogmo HK
    Acta Oncol; 2011 Aug; 50(6):873-82. PubMed ID: 21767187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of using abbreviated scan protocols with population-based input functions for accurate kinetic modeling of [
    Sari H; Eriksson L; Mingels C; Alberts I; Casey ME; Afshar-Oromieh A; Conti M; Cumming P; Shi K; Rominger A
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):257-265. PubMed ID: 36192468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
    Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
    J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
    Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
    Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.